B
Bounleut Phanavanh Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
16 h-index
33 pubs
2,031 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Bounleut Phanavanh's research at the National Center for Toxicological Research investigates mechanisms of drug-induced cardiotoxicity. Recent work has focused on doxorubicin-induced cardiotoxicity in mice, exploring its delayed-onset and subclinical manifestations. Phanavanh has also studied microRNA-34a-5p as a potential circulating biomarker for chronic cardiotoxicity. Additional research includes investigating the role of the apelin-APJ pathway in sex-related differential cardiotoxicity and evaluating a human placental barrier model for drug transfer studies. Phanavanh has published 27 papers with over 2,000 citations and an h-index of 16. Key collaborators include Vikrant Vijay, James C. Fuscoe, Kimo C. Stine, and Carrie L. Moland.
Metrics
- h-index: 16
- Publications: 33
- Citations: 2,031
Selected Publications
-
Correction: Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study (2026)
-
Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study (2025)
-
Evaluation of a microphysiological human placental barrier model for studying placental drug transfer (2023)
-
Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice (2022)
-
MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity (2022)
-
Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice (2021)
Collaboration Network
Top Collaborators
Vikrant Vijay
United States Food and Drug Administration
5 shared publications
In database
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
- Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study
- Correction: Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study
Varsha G. Desai
4 shared publications
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
- Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study
James C. Fuscoe
National Center for Toxicological Research
4 shared publications
In database
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
- Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study
Tao Han
National Center for Toxicological Research (US)
3 shared publications
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
Carrie L. Moland
National Center for Toxicological Research
3 shared publications
In database
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
Taewon Lee
Department of Mathematical Sciences (RU)
3 shared publications
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study
Kimo C. Stine
University of Arkansas for Medical Sciences
3 shared publications
In database
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study
David P. Douglass
University of Arkansas for Medical Sciences (US)
2 shared publications
- Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study
- Correction: Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study
Nysia I. George
United States Food and Drug Administration
2 shared publications
In database
- Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study
- Correction: Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study
Kelly J. Davis
National Center for Toxicological Research (US)
1 shared publication
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
Levan Muskhelishvili
National Center for Toxicological Research (US)
1 shared publication
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
Eugene H. Herman
National Cancer Institute (MY)
1 shared publication
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
Ana Clara P. Azevedo‐Pouly
National Center for Toxicological Research
1 shared publication
In database
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
Javier R. Revollo
United States Food and Drug Administration
1 shared publication
In database
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
Baikuntha Aryal
Center for Drug Evaluation and Research (US)
1 shared publication
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
Similar Researchers
Based on overlapping research topics
Carrie L. Moland
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Cardiovascular Function and Risk Factors
MicroRNA in disease regulation
Kate Steed
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cardiovascular Function and Risk Factors
Disease Mechanisms Research
C. Michael Foley
University of Arkansas at Fayetteville
Pharmacological Effects and Toxicity Studies
Cardiovascular Function and Risk Factors
Disease Mechanisms Research
Serena Van
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cardiovascular Function and Risk Factors
Disease Mechanisms Research
Brittney R. Garner
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Animal model studies
Bhawana Adhikari
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cardiovascular Function and Risk Factors
Disease Mechanisms Research